Loading...

Axonics, Inc.

AXNX•NASDAQ
Healthcare
Medical - Devices
$70.98
$0.00(0.00%)

Axonics, Inc. (AXNX) Stock Overview

Explore Axonics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.8/100

Key Financials

Market Cap3.6B
P/E Ratio-640.68
EPS (TTM)$-0.10
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$75.89

AXNX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Axonics, Inc. (AXNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $75.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -640.68 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;